ReviewArchives of microbiology2025
Reactive oxygen species and reactive nitrogen species are double-edged swords in Salmonella infection.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Salmonella contains a group of serovars, which are more than just enteropathogenic bacteria but dangerous pathogens causing systemic infection of human, livestock, and poultry. As an innate immune response, inflammation induces reactive oxygen species (ROS) and reactive nitrogen species (RNS) production from host cells in response to Salmonella infection. Generally, ROS and RNS are regarded as bactericidal substances for their ability to oxidize and modify the bacterial biomolecules including proteins, DNA, RNA, lipids, etc. However, excessive ROS and RNS damage the functions of host cells through the destroy of host biomolecules. Salmonella inhibits ROS/RNS production, eliminates toxic ROS/RNS, and mends damaged DNA/proteins using specific enzymes or proteins to avoid the killing of ROS/RNS. In hypoxic intracellular environment or intestinal lumen, Salmonella exploits the chemical reaction products of ROS or RNS to promote its growth during infection. This review article provides deep insights for understanding the functions of ROS/RNS in Salmonella infection.
Indexed as
Identifiers
40768042What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.